Establishing a Robust Data Integrity Program for FDA and the European Regulatory Agencies
DUBLIN, Oct. 30, 2019 /PRNewswire/ -- The "Establishing a Robust Data Integrity Program" webinar has been added to ResearchAndMarkets.com's offering.
Data integrity is defined as the maintenance of, and the assurance of the accuracy and consistency of, data over its entire life-cycle. Data Integrity is a global issue with both FDA and the European Regulatory Agencies majorly focusing on the topic during compliance inspections.
Multiple FDA warning letters and EU GMP non-compliance reports have highlighted major data integrity failures and falsification within companies around the globe.
The regulatory concern has been responded to by both domestic and foreign governing agencies with the FDA, EMA, MHRA, WHO, and PIC/S all having recently published data integrity standards and guidelines. This webinar will detail a data integrity governance program and principles for defining quality and data integrity into processes and systems.
As regulators are focusing their inspection on data integrity, it is important that managers, supervisors and users in regulated GMP laboratories understand the issues relative to data integrity and implement robust programs to ensure compliance. Topic 1: Regulatory Guidance Review
Topic 2: Review all Elements Important to Maintaining Dat Integrity
Topic 3: Key Data Integrity Topics
Topic 4: What are GMP-relevant Data?
Topic 5: Why Is An Audit Trail Review Important?
Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.
Research and Markets
SOURCE Research and Markets
Top Security Threats to Your Corporate Assets
Keynote Presentation TBA
Hybrid Work â€“ Itâ€™s Complicated